Value Aligned Research Advisors LLC Takes $274.51 Million Position in Astera Labs, Inc. $ALAB

Value Aligned Research Advisors LLC acquired a new position in Astera Labs, Inc. (NASDAQ:ALAB) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 568,316 shares of the company’s stock, valued at approximately $274,508,000. Astera Labs makes up 0.7% of Value Aligned Research Advisors LLC’s investment portfolio, making the stock its 24th largest position.

Other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. grew its holdings in Astera Labs by 0.6% during the fourth quarter. Vanguard Group Inc. now owns 13,827,506 shares of the company’s stock valued at $2,300,344,000 after purchasing an additional 84,365 shares during the period. BlackRock Inc. purchased a new stake in Astera Labs in the second quarter worth about $6,609,581,000. Atreides Management LP raised its stake in shares of Astera Labs by 108.9% in the first quarter. Atreides Management LP now owns 3,365,787 shares of the company’s stock worth $368,890,000 after buying an additional 1,754,593 shares during the period. State Street Corp raised its stake in shares of Astera Labs by 32.5% in the fourth quarter. State Street Corp now owns 3,099,809 shares of the company’s stock worth $515,684,000 after buying an additional 760,358 shares during the period. Finally, Geode Capital Management LLC lifted its position in shares of Astera Labs by 4.5% during the 4th quarter. Geode Capital Management LLC now owns 2,429,078 shares of the company’s stock valued at $403,598,000 after buying an additional 104,935 shares in the last quarter. 60.47% of the stock is owned by institutional investors.

Astera Labs Stock Up 4.8%

Shares of Astera Labs stock opened at $304.09 on Friday. The stock’s 50-day simple moving average is $344.94 and its 200-day simple moving average is $249.37. Astera Labs, Inc. has a 52 week low of $97.89 and a 52 week high of $499.48. The company has a market capitalization of $52.76 billion, a price-to-earnings ratio of 150.54 and a beta of 3.84.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The firm had revenue of $392.40 million during the quarter, compared to analyst estimates of $360.85 million. During the same quarter in the prior year, the company posted $0.44 earnings per share. The business’s quarterly revenue was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, equities analysts expect that Astera Labs, Inc. will post 2.7 earnings per share for the current year.

Insider Buying and Selling

In other Astera Labs news, CEO Jitendra Mohan sold 90,630 shares of the stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the completion of the sale, the chief executive officer directly owned 1,266,665 shares of the company’s stock, valued at $431,109,432.75. This trade represents a 6.68% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Stefan A. Dyckerhoff sold 8,994 shares of Astera Labs stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $450.00, for a total transaction of $4,047,300.00. Following the sale, the director owned 4,631 shares in the company, valued at approximately $2,083,950. The trade was a 66.01% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 419,244 shares of company stock worth $163,135,169 in the last quarter. 10.40% of the stock is owned by insiders.

Analysts Set New Price Targets

ALAB has been the subject of a number of recent research reports. UBS Group reiterated a “neutral” rating and set a $425.00 price objective on shares of Astera Labs in a research note on Wednesday, August 5th. Weiss Ratings restated a “hold (c)” rating on shares of Astera Labs in a research note on Tuesday, August 18th. JPMorgan Chase & Co. lifted their price target on shares of Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a report on Wednesday, May 6th. Morgan Stanley upped their price target on shares of Astera Labs to $335.00 and gave the stock an “overweight” rating in a research report on Monday, August 3rd. Finally, Stifel Nicolaus upped their price target on shares of Astera Labs from $260.00 to $460.00 and gave the stock a “buy” rating in a research report on Wednesday, June 24th. One research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and eight have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $333.00.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.